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Peritonitis – cells, cytokines, and local defense
E d i t o r i a l
Peritoneal dialysis is the first-line renal replacement
therapy in Hong Kong (1). Peritonitis is a common and
serious complication of continuous ambulatory peritoneal
dialysis (CAPD). Although the incidence of gram-positive
peritonitis has declined after the disconnect dialysis
system became popular, and antibiotic therapy is effective
for most episodes, peritonitis remains the major cause of
technique failure and conversion to hemodialysis in
CAPD patients.
Studies have shown that the resident cells of the peritoneal
cavity, including peritoneal macrophages and mesothelial
cells, contribute to the initiation, amplification, and
resolution of peritoneal inflammation. Although it is
widely accepted that resident peritoneal macrophages
form the first line of defense against peritoneal infection,
recent evidence suggests that the interaction between
macrophage and mesothelial cells is pivotal to the
activation and subsequent amplification of the peritoneal
response to infection. In this issue of the Journal, Chow
et al (2) and Guo et al (3) provide further information on
this aspect.
In the first article, Chow et al (2) studied 16 cases of
peritonitis caused by Mycobacterium tuberculosis, a
classic bacteria with intracellular persistence. The authors
found that patients with a good therapeutic response had
a significantly higher peritoneal fluid macrophage cell
count than those patients who failed treatment. In contrast,
the lymphocyte count in peritoneal dialysis effluent (PDE)
did not affect clinical outcome. It goes without saying
that the macrophage is the major cellular component to
tackle tuberculous infection. The problem is whether
boosting the phagocytic activity–for example, by
interferon (4) or vitamin D analogue (5)–can improve
the therapeutic response of tuberculous peritonitis.
What is the relevance of this article? Although tuberculous
peritonitis is not common, intracellular persistence of
bacteria is. Corynebacterium, a diphtheroid Gram positive
bacterium, shared a similar cell wall component and
several similar biologic properties with mycobacterium
(6). Furthermore, mesothelial cells can directly ingest and
digest several bacteria (7). Interestingly, Staphylococcus
aureus persists in the cytoplasm of mesothelial cells after
being ingested (8)–an exceptional means to protect the
bacteria from phagocytosis by neutrophil.
However, not all is good with neutrophil in peritonitis.
Longitudinal changes in peritoneal transport and
ultrafiltration in CAPD patients correlated with cumulated
white cell count during peritonitis (9), presumably a result
of unchecked mesothelial damage by neutrophil. How
does peritoneum control inflammation? In the second
article, Guo et al (3) provide some insights in this respect.
They observed that soluble intercellular adhesion
molecule-1 (sICAM-1) level was reduced in the serum
but increased in the PDE of patients with peritonitis. The
change was reversible after the treatment of peritonitis,
and is distinctly different from spontaneous bacterial
peritonitis of cirrhotic patients, whose serum and ascitic
fluid sICAM-1 levels are both increased (10). Although
the source of sICAM-1 was not studied, the reversal
change in serum and PDE did suggest local production
by resident peritoneal cells.
What is the role of sICAM-1 inside the peritoneal cavity?
In most biologic systems, sICAM-1 is shed from ICAM-
1 expression cells by proteolytic cleavage, and secreted
into the surrounding fluid. Soluble ICAM-1 binds to
lymphocyte function-associated antigen-1 and MAC-1
integrins, and competes with membrane-bound ICAM-1
for activated leukocytes (11). Mesothelial cells produce
C-x-C and C-C chemokines that contribute to the
intraperitoneal neutrophil migration, which is
significantly reduced in the presence of sICAM-1 (12).
It seems probable that sICAM-1 forms a local control of
the inflammatory cascade, and prevents excessive
recruitment of neutrophil and release of reactive oxygen
species.
Despite many recent advances, the story of cytokine and
cell-cell interaction in peritonitis is far from complete. It
should be pointed out that peritonitis is not only a serious
problem in clinical dialysis practice, but also an important
model in studying several fields of immunology, such as
chemotaxis and cell migration.
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